The Canopy Cancer Collective, a national nonprofit organization that strives to fuel better treatments and outcomes for pancreatic cancer patients, has awarded The Tisch Cancer...
The pancreas is a key metabolic regulator. When pancreatic beta cells cease producing enough insulin, blood sugar levels rise dangerously — a phenomenon known as...
In March 2020, Dr. Joseph Vinetz left the contemplative world of his Yale University infectious-disease laboratory and plunged into the covid ward at Yale New...
Investigators at the University of Miami Miller School of Medicine have designed RNA molecules that home to human pancreatic beta cells, the cells that produce...
In a recent study posted to the medRxiv* pre-print server, researchers used cardiac magnetic resonance (CMR) to show the one-year trajectory of cardiac impairment in...
Researchers at Lund University have discovered increased levels of a microRNA in type 2 diabetes, which has a negative effect on insulin secretion. Their experiments...
Scientists at Roswell Park Comprehensive Cancer Center have identified a potential new target for the treatment of pancreatic cancer. The study, published today in Cancer...
The gastrointestinal hormone secretin- often associated with its role in the pancreas- increases and improves both heart and kidney function, according to a new study....
Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate...
Research led by scientists at the Jonsson Comprehensive Cancer Center (JCCC) at UCLA provides new insights into molecular “crosstalk” in pancreas cancer cells, identifying vulnerabilities...
Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting targets to reduce heart disease risk. Fortunately, available therapies can...
A new Better Health marketing campaign has been launched today to help people prevent risks of developing serious illness and help reduce the risk of...
_1b78fec41a5143afb6e7b9ad317023d2-620x480-620x450.jpg "US Rep. Gaetz’s diagnosis of what’s driving insulin costs misses the root cause")
